International Journal of Radiation Oncology*Biology*Physics

The return of the snake oil salesmen
pp. 561-562(2)
Author: Glatstein E.

Polymer-conjugated paclitaxel as a radiosensitizing agent-a big step forward for combined modality therapy?
pp. 563-564(2)
Author: Tishler R.B.

A single fraction for all, or an argument for fractionation tailored to fit the needs of each individual patient with bone metastases?
pp. 565-567(3)
Authors: Chow E.; Lutz S.; Beyene J.

Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas
pp. 568-575(8)
Authors: Khalil A.A.; Bentzen S.M.; Bernier J.; Saunders M.I.; Horiot J.-C.; Van Den Bogaert W.; Cummings B.J.; Dische S.

In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer
pp. 576-582(7)
Authors: Dobrowsky W.; Dobrowsky E.; Wilson G.D.

CT image-guided intensity-modulated therapy for paraspinal tumors using stereotactic immobilization
pp. 583-593(11)
Authors: Yenice K.M.; Lovelock D.M.; Hunt M.A.; Lutz W.R.; Fournier-Bidoz N.; Hua C.-H.; Yamada J.; Bilsky M.; Lee H.; Pfaff K.; Spirou S.V.; Amols H.I.

Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases
pp. 594-605(12)
Authors: Wu J.S.-Y.; Wong R.; Johnston M.; Bezjak A.; Whelan T.; on behalf of the Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group

Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation
pp. 606-616(11)
Authors: Forster K.M.; Smythe W.R.; Starkschall G.; Liao Z.; Takanaka T.; Kelly J.F.; Vaporciyan A.; Ahamad A.; Dong L.; Salehpour M.; Komaki R.; Stevens C.W.

Secretory activity and cell cycle alteration of alveolar type II cells in the early and late phase after irradiation
pp. 617-625(9)
Authors: Willner J.; Vordermark D.; Schmidt M.; Gassel A.; Flentje M.; Wirtz H.

Process of care and preliminary outcome in limited-stage small-cell lung cancer: results of the 1995-1997 patterns of care study in Japan
pp. 626-632(7)
Authors: Uno T.; Sumi M.; Sawa Y.; Teshima T.; Hara R.; Ikeda H.; Inoue T.; The Japanese PCS Working Subgroup of Lung Cancer

Breast radiotherapy with inclusion of internal mammary nodes: a comparison of techniques with three-dimensional planning
pp. 633-644(12)
Authors: Severin D.; Connors S.; Thompson H.; Rathee S.; Stavrev P.; Hanson J.

Evidence-based medicine: its effect on treatment recommendations as illustrated by the changing role of postmastectomy irradiation to treat breast cancer
pp. 645-650(6)
Authors: Levitt S.H.; Aeppli D.; Nierengarten M.B.

Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system
pp. 651-658(8)
Authors: Fehlauer F.; Tribius S.; Holler U.; Rades D.; Kuhlmey A.; Bajrovic A.; Alberti W.

Respiratory gating for liver tumors: use in dose escalation
pp. 659-668(10)
Authors: Wagman R.; Yorke E.; Ford E.; Giraud P.; Mageras G.; Minsky B.; Rosenzweig K.

Chemoradiation for adenocarcinoma of the anus
pp. 669-678(10)
Authors: Papagikos M.; Crane C.H.; Skibber J.; Janjan N.A.; Feig B.; Rodriguez-Bigas M.A.; Hung A.; Wolff R.A.; Delclos M.; Lin E.; Cleary K.

Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectable pancreatic cancer
pp. 679-687(9)
Authors: Ashamalla H.; Zaki B.; Mokhtar B.; Colella F.; Selim H.; Krishnamurthy M.; Ross P.

Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy)
pp. 688-694(7)
Authors: Cozzarini C.; Fiorino C.; Ceresoli G.L.; Cattaneo G.M.; Bolognesi A.; Calandrino R.; Villa E.

Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables
pp. 695-706(12)
Authors: Ferrigno R.; Campos de Oliveira Faria S.L.; Weltman E.; Salvajoli J.V.; Segreto R.A.; Pastore A.; Nadalin W.

Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability
pp. 707-712(6)
Authors: Milas L.; Mason K.A.; Hunter N.; Li C.; Wallace S.

EGFR blockade with ZD1839 (''Iressa'') potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma
pp. 713-723(11)
Authors: Solomon B.; Hagekyriakou J.; Trivett M.K.; Stacker S.A.; McArthur G.A.; Cullinane C.

Comparing different NTCP models that predict the incidence of radiation pneumonitis
pp. 724-735(12)
Authors: Seppenwoolde Y.; Lebesque J.V.; de Jaeger K.; Belderbos J.S.A.; Boersma L.J.; Schilstra C.; Henning G.T.; Hayman J.A.; Martel M.K.; Ten Haken R.K.

Application of biological effective dose (BED) to estimate the duration of symptomatic relief and repopulation dose equivalent in palliative radiotherapy and chemotherapy
pp. 736-742(7)
Authors: Jones B.; Cominos M.; Dale R.G.

Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the Phase I trial EORTC 11961 using a gamma-ray telescope
pp. 743-756(14)
Authors: Verbakel W.F.A.R.; Sauerwein W.; Hideghety K.; Stecher-Rasmussen F.

Optimization of conformal thoracic radiotherapy using cone-beam CT imaging for treatment verification
pp. 757-767(11)
Authors: Sidhu K.; Ford E.C.; Spirou S.; Yorke E.; Chang J.; Mueller K.; Todor D.; Rosenzweig K.; Mageras G.; Chui C.; Ling C.C.; Amols H.

Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma
pp. 768-775(8)
Authors: Ahamad A.; Stevens C.W.; Smythe W.R.; Vaporciyan A.A.; Komaki R.; Kelly J.F.; Liao Z.; Starkschall G.; Forster K.M.

Intensity-modulated radiation therapy (IMRT) for locally advanced paranasal sinus tumors: incorporating clinical decisions in the optimization process
pp. 776-784(9)
Authors: Tsien C.; Eisbruch A.; McShan D.; Kessler M.; Marsh R.; Fraass B.

Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes
pp. 785-792(8)
Authors: Lomax A.J.; Cella L.; Weber D.; Kurtz J.M.; Miralbell R.

Megavoltage cone-beam computed tomography using a high-efficiency image receptor
pp. 793-803(11)
Authors: Seppi E.J.; Munro P.; Johnsen S.W.; Shapiro E.G.; Tognina C.; Jones D.; Pavkovich J.M.; Webb C.; Mollov I.; Partain L.D.; Colbeth R.E.

Procedures for high precision setup verification and correction of lung cancer patients using CT-simulation and digitally reconstructed radiographs (DRR)
pp. 804-810(7)
Authors: Van Sornsen de Koste J.R.; de Boer H.C.J.; Schuchhard-Schipper R.H.; Senan S.; Heijmen B.J.M.

Development of a semi-automatic alignment tool for accelerated localization of the prostate
pp. 811-824(14)
Authors: Hua C.; Lovelock D.M.; Mageras G.S.; Katz M.S.; Mechalakos J.; Lief E.P.; Hollister T.; Lutz W.R.; Zelefsky M.J.; Ling C.C.

Biologically effective dose (BED) for interstitial seed implants containing a mixture of radionuclides with different half-lives
pp. 825-834(10)
Authors: Chen Z.; Nath R.

Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy
pp. 835-841(7)
Authors: Pos F.J.; Koedooder K.; Hulshof M.C.C.M.; van Tienhoven G.; Gonzalez Gonzalez D.

Dose effects of stents in intravascular brachytherapy for in-stent restenosis: a Monte Carlo calculation
pp. 842-848(7)
Author: Li X.A.

In response to Dr. Nieder
pp. 849-849(1)
Author: Levin V.A.

Glioma treatment, radionecrosis, and growth factors. in regard to Levin et al., IJROBP 2002;53:58-66
pp. 849-849(1)
Author: Nieder C.

Palliation of esophageal cancer: there is no clear winner
pp. 849-850(2)
Author: Shakespeare T.P.

In response to Dr. Shakespeare
pp. 850-850(1)
Authors: Sur R.; Nag S.; Levin V.

Evaluating locoregional recurrence in breast cancer
pp. 850-851(2)
Authors: Lawrence G.; Crawford J.

In response to Drs. Lawrence and Crawford
pp. 851-851(1)
Author: Buchholz T.A.

Commentary on IMRT and cancer of the prostate
pp. 851-852(2)
Authors: Schulz R.J.; Kagan A.R.

In response to Drs. Schulz and Kagan
pp. 852-853(2)
Authors: Zelefsky M.J.; Leibel S.A.

In response to Drs. Soomal, Saran, and Brada
pp. 853-854(2)
Authors: Woo S.Y.; Teh B.S.; Grant W.H.; Butler E.B.; Chintagumpala M.M.

In regard to Huang et al.: intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity IJROBP 2002;52:599-605
pp. 853-853(1)
Authors: Soomal R.; Saran F.; Brada M.